Literature DB >> 8795633

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.

E Masliah1, A Sisk, M Mallory, L Mucke, D Schenk, D Games.   

Abstract

Overexpression of mutated human amyloid precursor protein (hAPP717V-->F) under control of platelet-derived growth factor promoter (PDAPP minigene) in transgenic (tg) mice results in neurodegenerative changes similar to Alzheimer's disease (AD). To clarify the pathology of these mice, we studied images derived from laser scanning confocal and electron microscopy and performed comparisons between PDAPP tg mice and AD. Similar to AD, neuritic plaques in PDAPP tg mouse contained a dense amyloid core surrounded by anti-hAPP- and antineurofilament-immunoreactive dystrophic neurites and astroglial cells. Neurons were found in close proximity to plaques in PDAPP tg mice and, to a lesser extent, in AD. In PDAPP tg mice, and occasionally in AD, neuronal processes contained fine intracellular amyloid fibrils in close proximity to the rough endoplasmic reticulum, coated vesicles, and electron-dense material. Extracellular amyloid fibrils (9-11 nm in diameter) were abundant in PDAPP tg and were strikingly similar to those observed in AD. Dystrophic neurites in plaques of PDAPP tg mouse and AD formed synapses and contained many dense multilaminar bodies and neurofilaments (10 nm). Apoptotic-like figures were present in the tg mice. No paired helical filaments have yet been observed in the heterozygote PDAPP tg mice. In summary, this study shows that PDAPP tg mice develop massive neuritic plaque formation and neuronal degeneration similar to AD. These findings show that overproduction of hAPP717V-->F in tg mice is sufficient to cause not only amyloid deposition, but also many of the complex subcellular degenerative changes associated with AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795633      PMCID: PMC6578961     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

2.  Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques.

Authors:  H M Wisniewski; M Barcikowska; E Kida
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Neuronal changes induced by intrathecal vincristine sulfate.

Authors:  S S Schochet; P W Lampert; K M Earle
Journal:  J Neuropathol Exp Neurol       Date:  1968-10       Impact factor: 3.685

4.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

5.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

Authors:  J Murrell; M Farlow; B Ghetti; M D Benson
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

6.  Immunohistochemical evidence for apoptosis in Alzheimer's disease.

Authors:  J H Su; A J Anderson; B J Cummings; C W Cotman
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

7.  Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.

Authors:  E Masliah; M Mallory; T Deerinck; R DeTeresa; S Lamont; A Miller; R D Terry; B Carragher; M Ellisman
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

8.  Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.

Authors:  P Cras; M Kawai; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.

Authors:  G K Wilcock; M M Esiri; D M Bowen; A O Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.

Authors:  E M Rockenstein; L McConlogue; H Tan; M Power; E Masliah; L Mucke
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  114 in total

1.  Microglia in Alzheimer's disease and transgenic models. How close the fit?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Authors:  M Stalder; A Phinney; A Probst; B Sommer; M Staufenbiel; M Jucker
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.

Authors:  R Planells-Cases; M Caprini; J Zhang; E M Rockenstein; R R Rivera; C Murre; E Masliah; M Montal
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

4.  Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.

Authors:  W Xia; J Zhang; R Perez; E H Koo; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

6.  Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.

Authors:  John F Reilly; Dora Games; Russell E Rydel; Stephen Freedman; Dale Schenk; Warren G Young; John H Morrison; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

Review 7.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 8.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 9.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

10.  Drugs for Alzheimer's disease.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.